150 related articles for article (PubMed ID: 8865457)
21. Genetic linkage analysis in hereditary non-polyposis colon cancer syndrome.
Froggatt NJ; Koch J; Davies R; Evans DG; Clamp A; Quarrell OW; Weissenbach J; Hodgson SV; Ponder BA; Barton DE
J Med Genet; 1995 May; 32(5):352-7. PubMed ID: 7616541
[TBL] [Abstract][Full Text] [Related]
22. DNA mismatch repair in lymphoblastoid cells from hereditary non-polyposis colorectal cancer (HNPCC) patients is normal under conditions of rapid cell division and increased mutational load.
Tomlinson IP; Hampson R; Karran P; Bodmer WF
Mutat Res; 1997 Mar; 383(2):177-82. PubMed ID: 9088350
[TBL] [Abstract][Full Text] [Related]
23. The hMSH2 and hMLH1 genes in hereditary nonpolyposis colorectal cancer.
Lynch PM
Surg Oncol Clin N Am; 2009 Oct; 18(4):611-24. PubMed ID: 19793569
[TBL] [Abstract][Full Text] [Related]
24. [Microsatellite instability--a new aspects in genetics and molecular biology of hereditary nonpolyposis and sporadic colorectal tumors].
Kullmann F; Bocker T; Schölmerich J; Rüschoff J
Z Gastroenterol; 1996 Dec; 34(12):813-22. PubMed ID: 9082661
[TBL] [Abstract][Full Text] [Related]
25. Incorporation of somatic BRAF mutation testing into an algorithm for the investigation of hereditary non-polyposis colorectal cancer.
Loughrey MB; Waring PM; Tan A; Trivett M; Kovalenko S; Beshay V; Young MA; McArthur G; Boussioutas A; Dobrovic A
Fam Cancer; 2007; 6(3):301-10. PubMed ID: 17453358
[TBL] [Abstract][Full Text] [Related]
26. Upper urinary tract urothelial cell carcinomas and other urological malignancies involved in the hereditary nonpolyposis colorectal cancer (lynch syndrome) tumor spectrum.
Rouprêt M; Yates DR; Comperat E; Cussenot O
Eur Urol; 2008 Dec; 54(6):1226-36. PubMed ID: 18715695
[TBL] [Abstract][Full Text] [Related]
27. [Clinical features and hMSH2/hMLH1 germline mutation screening of Chinese hereditary nonpolyposis colorectal cancer patients].
Liu SR; Wang ZJ; Zhao B; Wan YL; Huang YT
Zhonghua Yi Xue Za Zhi; 2004 May; 84(9):714-7. PubMed ID: 15200905
[TBL] [Abstract][Full Text] [Related]
28. [A new oncogenetic service of counseling and diagnosing for hereditary non-polyposis colorectal cancer (HNPCC)].
Goldberg Y; Porat R; Sagi M; Eilat A; Kedar I; Shochat C; Mendelson S; Hamburger T; Nissan A; Hubert A; Shalev S; Bercovich D; Pikarski E; Lerer I; Abeliovich D; Pretetz T
Harefuah; 2007 Jul; 146(7):510-4, 576, 575. PubMed ID: 17803162
[TBL] [Abstract][Full Text] [Related]
29. Suspected hereditary nonpolyposis colorectal cancer: International Collaborative Group on Hereditary Non-Polyposis Colorectal Cancer (ICG-HNPCC) criteria and results of genetic diagnosis.
Park JG; Vasen HF; Park KJ; Peltomaki P; Ponz de Leon M; Rodriguez-Bigas MA; Lubinski J; Beck NE; Bisgaard ML; Miyaki M; Wijnen JT; Baba S; Lynch HT
Dis Colon Rectum; 1999 Jun; 42(6):710-5; discussion 715-6. PubMed ID: 10378593
[TBL] [Abstract][Full Text] [Related]
30. [Review of the molecular genetics of the Lynch syndrome].
Dolezal T; Panczak A; Krepelová A
Cesk Fysiol; 1998 Mar; 47(1):4-12. PubMed ID: 9650415
[TBL] [Abstract][Full Text] [Related]
31. Simplified MSI marker panel for diagnosis of colorectal cancer.
Shemirani AI; Haghighi MM; Zadeh SM; Fatemi SR; Taleghani MY; Zali N; Akbari Z; Kashfi SM; Zali MR
Asian Pac J Cancer Prev; 2011; 12(8):2101-4. PubMed ID: 22292659
[TBL] [Abstract][Full Text] [Related]
32. Expression of the mismatch repair gene hMSH2 in sporadic colorectal cancer.
Maeda K; Nishiguchi Y; Onoda N; Otani H; Nakata B; Yamada S; Okuno M; Sowa M; Chung KH
Int J Oncol; 1998 Dec; 13(6):1147-51. PubMed ID: 9824623
[TBL] [Abstract][Full Text] [Related]
33. Promoter hypermethylation frequency and BRAF mutations distinguish hereditary non-polyposis colon cancer from sporadic MSI-H colon cancer.
McGivern A; Wynter CV; Whitehall VL; Kambara T; Spring KJ; Walsh MD; Barker MA; Arnold S; Simms LA; Leggett BA; Young J; Jass JR
Fam Cancer; 2004; 3(2):101-7. PubMed ID: 15340260
[TBL] [Abstract][Full Text] [Related]
34. Germline hMSH2 and hMLH1 gene mutations in incomplete HNPCC families.
Wang Q; Desseigne F; Lasset C; Saurin JC; Navarro C; Yagci T; Keser I; Bagci H; Luleci G; Gelen T; Chayvialle JA; Puisieux A; Ozturk M
Int J Cancer; 1997 Dec; 73(6):831-6. PubMed ID: 9399661
[TBL] [Abstract][Full Text] [Related]
35. Extensive molecular screening for hereditary non-polyposis colorectal cancer.
Dieumegard B; Grandjouan S; Sabourin JC; Le Bihan ML; Lefrère I; Bellefqih ; Pignon JP; Rougier P; Lasser P; Bénard J; Couturier D; Bressac-de Paillerets B
Br J Cancer; 2000 Feb; 82(4):871-80. PubMed ID: 10732761
[TBL] [Abstract][Full Text] [Related]
36. [Identification and genetic counseling of people with HNPCC (hereditary nonpolyposis colorectal cancer): old and new research goals].
Müller H; Dobbie Z; Heinimann K
Schweiz Med Wochenschr; 1999 Dec; 129(50):1978-85. PubMed ID: 10637951
[TBL] [Abstract][Full Text] [Related]
37. Genetic identification and management of hereditary nonpolyposis colorectal cancer.
Park JG; Yuan Y
Int J Oncol; 1998 Apr; 12(4):947-55. PubMed ID: 9499460
[TBL] [Abstract][Full Text] [Related]
38. Genetic testing and counseling for hereditary forms of colorectal cancer.
Petersen GM; Brensinger JD; Johnson KA; Giardiello FM
Cancer; 1999 Dec; 86(11 Suppl):2540-50. PubMed ID: 10630180
[TBL] [Abstract][Full Text] [Related]
39. Genetic susceptibility to non-polyposis colorectal cancer.
Lynch HT; de la Chapelle A
J Med Genet; 1999 Nov; 36(11):801-18. PubMed ID: 10544223
[TBL] [Abstract][Full Text] [Related]
40. The hereditary nonpolyposis colorectal cancer syndrome: genetics and clinical implications.
Chung DC; Rustgi AK
Ann Intern Med; 2003 Apr; 138(7):560-70. PubMed ID: 12667026
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
